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Abstract
Sepsis is a severe clinical syndrome owing to its high mortality. Quick Sequential Organ Fail-
ure Assessment (qSOFA) score has been proposed for the prediction of fatal outcomes in
sepsis syndrome in emergency departments. Due to the low predictive performance of the
qSOFA score, we propose a modification to the score by adding age. We conducted a multi-
center, retrospective cohort study among regional referral centers from various regions of
the country. Participants recruited data of patients admitted to emergency departments and
obtained a diagnosis of sepsis syndrome. Crude in-hospital mortality was the primary end-
point. A generalized mixed-effects model with random intercepts produced estimates for
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adverse outcomes. Model-based recursive partitioning demonstrated the effects and
thresholds of significant covariates. Scores were internally validated. The H measure com-
pared performances of scores. A total of 580 patients from 22 centers were included for fur-
ther analysis. Stages of sepsis, age, time to antibiotics, and administration of carbapenem
for empirical treatment were entered the final model. Among these, severe sepsis (OR,
4.40; CIs, 2.35–8.21), septic shock (OR, 8.78; CIs, 4.37–17.66), age (OR, 1.03; CIs, 1.02–
1.05) and time to antibiotics (OR, 1.05; CIs, 1.01–1.10) were significantly associated with
fatal outcomes. A decision tree demonstrated the thresholds for age. We modified the quick
Sequential Organ Failure Assessment (mod-qSOFA) score by adding age (> 50 years old =
one point) and compared this to the conventional score. H-measures for qSOFA and mod-
qSOFA were found to be 0.11 and 0.14, respectively, whereas AUCs of both scores were
0.64. We propose the use of the modified qSOFA score for early risk assessment among
sepsis patients for improved triage and management of this fatal syndrome.
Introduction
Despite the growing accessibility to effective antibiotics in medical practice, sepsis syndrome is
still a serious infectious disease with high morbidity and mortality [1]. Sepsis syndrome con-
sisted of three sequential stages: sepsis, severe sepsis, and septic shock [2]. Sepsis was defined
as having two or more of the Systemic Inflammatory Response Syndrome (SIRS) criteria
attributed to a suspected or documented infection [2]. If sepsis was misdiagnosed or unnoticed
for any reason, severe sepsis and septic shock develop consecutively. Studies have shown that
mortality rates increase serially in sepsis, severe sepsis, and septic shock from 10% to 80% [3].
SIRS based sepsis definition is broad and nonspecific which causes a considerable number
of false diagnosis [4,5]. Recently, a task force proposed new sepsis definitions which were
grounded on the SOFA or qSOFA scores ( 2 points) [6]. Early studies indicated that the pre-
dictive performance of sepsis-3 definitions was superior to SIRS based definitions in predicting
adverse outcomes [7].
Using qSOFA score in emergency departments (ED) seems to be a practical substitute to
stratify patients with infection. However, the debate on the performance of sepsis-3 definitions
are ongoing [8] and, in recent studies, sepsis-3 definitions yielded poor sensitivity for predict-
ing adverse outcomes [9]. Refining the predictive performance of qSOFA with a reasonable
trade-off between misclassification types is of interest.
In this study, we studied the marginal effects of risk variables associated with adverse out-
comes and based on our estimates we developed a modification to improve the cost-sensitive
predictive performance of qSOFA in sepsis.
Materials and methods
Study design
We performed a multi-center, retrospective cohort study among adult patients admitted to the
emergency services of regional referral hospitals with a diagnosis of sepsis syndrome from
March 2013 to January 2016.
The Ethical Committee of Istanbul Medeniyet University (Istanbul, Turkey) approved this
study with a waiver of informed consent (#2015/0142).
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Study setting, population, and data collection
Referral centers from various regions of Turkey participated in the study. At least two physi-
cians specializing in related fields extracted potential cases from the hospital databases using
sepsis and SIRS-related ICD-10 codes. Participants screened medical records for the eligibility
of patients according to study inclusion and exclusion criteria. Finally, researchers extracted
data from medical charts of patients and the hospital records. The centers submitted their data
on a spreadsheet.
Definitions
Study inclusion criteria were as follows: i. Age > 17 years old; ii. Outpatient with a diagnosis of
sepsis syndrome upon admission to the emergency department (ED). Patients with incomplete
outcome information and those with sepsis that developed in the hospital after being admitted
for other medical reasons were excluded from the analysis.
Sepsis was defined as having two or more of SIRS criteria attributed to a suspected or docu-
mented infection. Severe sepsis was defined as sepsis plus organ dysfunction attributed to sep-
sis-induced tissue hypoperfusion. Septic shock was defined as severe sepsis plus refractory
hypotension despite adequate fluid resuscitation [10]. Organ dysfunctions were as defined
elsewhere [10].
Elapsed time to antibiotics was the elapsed time between ED admission and the administra-
tion of antibiotics. Underlying diseases were grouped according to principal component analy-
sis. Accordingly, patients were coded as positive for underlying diseases, including any of
diabetes, chronic renal disease, and solid organ malignancies.
Data on age, gender, blood culture results, carbapenem administration as initial treatment
approach, intensive care unit (ICU) stay during the course of the disease, mechanical ventila-
tion in ICU, suspected source of infection upon admission, leucocyte count upon admission,
length of hospital stay (days), and SOFA score were also collected.
The outcome of interest was in-hospital crude mortality.
We performed a post-hoc modification of the qSOFA score by including age as the fourth
parameter. Eventually, we compared the predictive performance for the outcome of the mod-
qSOFA score against the classical qSOFA.
Statistical analysis
Data management and statistical analysis were performed using the open-source statistical
packages on R (a language and environment for statistical computing, R Foundation for Statis-
tical Computing, Vienna, Austria. URL: https://www.R-project.org).
Continuous variables if non-normally distributed were presented as median, first and third
quartiles and compared using the Kruskal-Wallis test in a univariate analysis. Otherwise,
continuous variables were presented as means and standard deviations and compared using
Students t-test. Categorical variables were compared using chi-squared or, where required,
Fisher’s exact test.
We imputed missing values after testing the missing mechanisms of variables for missing
completely at random (MCAR) [11]. Missing variables were imputed 20 times by multivariate
imputations with chained equations by using the best-suited method [12]. Estimates were
pooled according to Rubin’s rules. We also generated a complete data set by aggregating
twenty imputations to medians. Since the estimates from the aggregated data set are almost
identical to the pooled estimates, we used the aggregated single data set for further analysis.
To estimate the effects of the variables, we fitted a generalized linear mixed-effects model
with random intercepts. We selected the final model using the least absolute shrinkage and
A modified quick SOFA scale for risk assessment in sepsis syndrome
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selection operator (LASSO) without random effects [13] and Akaike’s information criterion
(AIC/BIC) with random effects among all potential risk variables. We tested the multicolli-
nearity between risk variables, and if it exists, we avoided collinearity by dropping the respon-
sible variable from the model. Interactions between the covariates of the final model were
examined one by one to each other.
To assess thresholds of significant predictors, we applied a generalized linear model-based
recursive partitioning by the “glmtree” function of the “partykit” package. The details of this
approach have been published [14].
We fragmented the database randomly to train and test subsets with a ratio of 0.5. Scores
were trained via linear discriminant analysis and tested by using the “hmeasure” package for
their classifying performances as described elsewhere [15]. We compared performances of
scores by H measure and area under Receiver Operating Characteristic (ROC) curve (AUC).
AUC estimates performances of scores by giving equal weights to the false negatives and false
positives whereas H measure enables to select a risk ratio according to the relative severities of
types of misclassification.
Results
A total of 22 referral centers recruited data from 660 eligible patients. Among these, 80 patients
were excluded from the analysis due to incomplete outcome data. These outcome data were
missing because those patients were i) staying in the hospital during the study, ii) transferred
to another hospital, or iii) the outcome data were not recorded into the hospital database. In
total, 580 patients were included in the analysis (S1 Table).
Table 1 presents the demographics and other features of the study population. Briefly, the
median age was 73 years old, and the male to female ratio was comparable. Two-thirds of the
patients (68.1%) admitted to the EDs at the early, mild stage of sepsis syndrome. A total of
32.6% of the patients died in the hospital.
Although all the centers obtained blood cultures timely using modern blood culture sys-
tems, microbiology laboratories were able to recover a microorganism only from one-third of
the samples (33.4%). E. coli was the most common bacteria (43.8% of all isolated bacteria) fol-
lowed by S. aureus (18.6%), coagulase-negative Staphylococcus (9.7%), K. pneumoniae (7.7%),
Enterococcus spp (5%), Enterobacteriaceae (4.1%), and S. pneumoniae (4.1%).
Almost one-fifth of the suspected sources of infections reported by the participants were
either unknown or not classified under major sites. Since this parameter is highly speculative,
and such a large portion could not be classified in our study, we did not include the suspected
source of infection in the analysis. However, a suspected source of lower respiratory tract
infection seems to be associated with adverse outcomes (data not shown). In a carefully
designed prospective study, this variable could be effectively examined to further improve dis-
crimination ability.
Three of the examined variables had missing observations. Age had one, elapsed time to
antibiotics had 47, and qSOFA score had 75 missing observations. The hypothesis of MCAR
was rejected at the 0.05 level by the normality test; therefore, dropping the missing observa-
tions would produce biased estimates. We imputed the missing observations 20 times, thereby
generating twenty different datasets. We also generated a complete data set that by aggregating
the set of twenty imputations to the medians.
Table 2 presents the univariate comparisons of the risk variables. The potential risk vari-
ables found to be significant from this comparison included: age, having a negative blood
culture, elapsed time to antibiotics, and stage of sepsis. However, we included all potential vari-
ables into the automatic variable selection routine. Age, elapsed time to antibiotics, stage of
A modified quick SOFA scale for risk assessment in sepsis syndrome
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sepsis, and empirical carbapenem usage were selected for the final model. Blood culture was
identified as a significant variable from the univariate analysis. However, the AIC/BIC-based
model selection excluded this variable due to its minimal contribution to the discrimination
power of the final model.
Table 3 presents the estimates from the mixed model with random intercepts for centers.
Briefly, the random part of the summary table shows that the intraclass correlation between
centers is high (ICCcenter, 0.323), which intends the need to account for random effects. The
fixed part of the summary table shows the association between stages of sepsis, age, and elapsed
time to antibiotics with fatal outcomes.
Fig 1 represents the model-based decision tree for fatal outcomes. The relationship between
fatal outcome and elapsed time to antibiotics, age, and stage of sepsis is presented. Briefly, all
Table 1. Demographics and other features of the cohort.
N = 580 N
Age 73 [59;81] 579
Gender: 580
Female 250 (43.1%)
Male 330 (56.9%)
Blood culture positive 194 (33.4%) 580
Carbapenem a 154 (26.6%) 580
ICU stay 295 (50.9%) 580
Mechanical ventilation 186 (32.7%) 568
Elapsed time (hours) b 3 [2; 5] 533
Underlying diseases c 580
No 296 (51.0%)
Yes 284 (49.0%)
Suspected source 580
Urinary tract 236 (40.7%)
Lower respiratory tract 151 (26.0%)
Skin-soft tissue 33 (5.69%)
Intra-abdominal 30 (5.17%)
Catheter related 18 (3.10%)
Other 61 (10.5%)
Unknown 51 (8.79%)
Leucocyte (mm^3) 14000 [9792;19500] 580
Length of hospital stay (days) 13.0 [8.00;18.0] 580
Stage of sepsis 580
Sepsis 395 (68.1%)
Severe sepsis 112 (19.3%)
Septic shock 73 (12.6%)
SOFA score 4 [2;8] 505
Died: 580
No 391 (67.4%)
Yes 189 (32.6%)
a Carbapenem, a carbapenem antibiotic was instituted at admission
b Elapsed time, time between application to ED and administration of an antibiotic
c Underling diseases, having any of diabetes, renal insufficiency or a malign disease (Underlying diseases are
presented individually in S2 Table).
https://doi.org/10.1371/journal.pone.0204608.t001
A modified quick SOFA scale for risk assessment in sepsis syndrome
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57 patients admitted to the ED with a diagnosis of sepsis, who were equal or younger than 50
years old and received antibiotics within three hours survived. Hence, we selected 50 years as
the threshold for age. The modified qSOFA (mod-qSOFA) adds one point for age> 50 years.
Positive test results were 2 points, as was in the traditional scale.
Fig 2 presents comparisons of predictive performances of scores. Briefly, H measure favors
the predictive performance of mod-qSOFA across various risk ratios. Values given in the table
is at the severity ratio of 0.25 which means that the cost of misclassifying a potentially non-
fatal case is 0.20 and a fatal case is 1 minus 0.20 (SR = c/1-c). AUC’s of both scores were equal.
SOFA score misclassified 35 fatal patients whereas mod-qSOFA misclassified only eight fatal
patients at an exchange of 58 non-fatal cases (FP) in the test subset (n = 289) of the data.
Discussion
In this study we developed and validated the mod-qSOFA score against the traditional version
using various metrics such as AUC and H measure. In the internal validation, the mod-qSOFA
score yielded better performance with the H measure metrics.
The AUC values were comparable between scores. However, AUC is not a valid metric
for evaluating scores in sepsis syndrome. In a medical situation with high mortality like sep-
sis syndrome, the performance of a classifier should be evaluated with cost-sensitive statis-
tics. The cost of misclassifying a potentially fatal case is not equivalent to the cost of
misclassifying a nonfatal case. In sepsis syndrome, the cost of a false negative (FN) is greater
than the cost of a false positive (FP). The AUC weights costs of FPs and FNs in a balanced
fashion. AUC of ROC, thus, is not suitable to measure the performances of classifiers in sep-
sis syndrome. The H measure allows to manually adjust the risk ratio according to which
type of misclassification is more serious. Risk ratio is the ratio of cost of FP over the cost of
Table 2. Univariate comparison of risk variables.
Died p
No
N = 391
Yes
N = 189
Age 69 [55;80] 78 [69;84] <0.001
Gender 0.995
Female 168 (67.2%) 82 (32.8%)
Male 223 (67.6%) 107 (32.4%)
Blood culture 0.006
Negative 245 (63.5%) 141 (36.5%)
Positive 146 (75.3%) 48 (24.7%)
Carbapenem a 0.254
No 281 (66.0%) 145 (34.0%)
Yes 110 (71.4%) 44 (28.6%)
Elapsed time (hours) b 2 [2;4] 4 [2;6] <0.001
Underlying diseases c 185 (65.1%) 99 (34.9%) 0.291
Stage of sepsis <0.001
Sepsis 312 (79.0%) 83 (21.0%)
Severe sepsis 59 (52.7%) 53 (47.3%)
Septic shock 20 (27.4%) 53 (72.6%)
a Carbapenem, a carbapenem antibiotic is instituted at admission
b Elapsed time, the time between application to ED and administration of an antibiotic
c Underling diseases, having any of diabetes, renal insufficiency or a malign disease
https://doi.org/10.1371/journal.pone.0204608.t002
A modified quick SOFA scale for risk assessment in sepsis syndrome
PLOS ONE | https://doi.org/10.1371/journal.pone.0204608 September 26, 2018 6 / 11
FN. The risk ratio is selected arbitrarily, largely depending on the expertise. To estimate sys-
tematically, thus, we presented the distribution of H measure values obtained across various
risk ratios (Fig 2). However, an optimum risk ratio that makes sense for sepsis syndrome
might be 0.25. A risk ratio of 0.25 means that the cost of false alarm is 0.2 whereas the cost of
missing a fatal case is 0.8.
In our study, using mod-qSOFA reduced the percentage of false negative decisions by 9%
(35-8/289) compare to the traditional qSOFA. In clinical practice, correctly identifying the
subset of patients with potentially adverse clinical outcomes is of major importance.
Our study documented how the patient outcome was affected in different stages of sepsis
syndrome by age and time to antibiotic treatment. Overall, in all the stages of sepsis syn-
drome, older ages were more associated with adverse outcomes. The relation between age
and adverse outcomes was connected to the frequency of comorbidities among elderly popu-
lations [16]. With high comorbidities, older patients have a high risk of adverse outcomes.
Studies using various cutoff points found a strong association between age and fatal out-
comes [16,17]. In all these studies, however, mortality augmented dramatically after the fif-
ties. In our study, we also noticed a similar effect of age on the outcome (Fig 1). Depending
on our results, we, propose adding age (> 50 years old = one point) as a fourth parameter to
the qSOFA score. In our database, this modification increased the predictive performance of
the qSOFA score on the outcome.
Our study also documented that elapsed time to antibiotic treatment was independently
associated with adverse outcomes, especially in the early stages of sepsis syndrome. Depending
on the elapsed time before admittance, awareness of the physician and the adequacy of the
empirical antibiotics, time to antibiotics in EDs might be highly variable [18]. Hence, we did
not consider to include time to antibiotics in mod-qSOFA.
Table 3. Estimates from generalized mixed models with random intercepts.
Single estimates a Pooled estimates b
Odds Ratio CI c p Odds Ratio CI p
Fixed Parts
(Intercept) 0.02 0.00–0.07 <0.001 0.02 0.01–0.10 < 0.001
Severe sepsis 4.40 2.35–8.21 <0.001 4.43 2.35–8.34 < 0.001
Septic shock 8.78 4.37–17.66 <0.001 9.18 4.54–18.50 < 0.001
Age 1.03 1.02–1.05 <0.001 1.03 1.01–1.05 0.002
Elapsed time d 1.05 1.01–1.10 .018 1.05 1.00–1.10 0.033
Carbapenem e 0.64 0.37–1.11 .112 0.68 0.39–1.18 0.17
Random Parts f
τ00, Center 1.566
NCenter 22
ICCCenter 0.323
Observations 580
Deviance 466.753
a Single estimates, estimates obtained from the aggregated data set,
b Pooled estimates, pooled estimates according to Rubin’s rule
c CI, 95% confidence intervals
d Elapsed time, the time between application to ED and administration of an antibiotic
e Carbapenem, a carbapenem antibiotic is instituted at admission
f τ00, Center, the variance of random intercept; ICCcenter; intraclass correlation coefficient (“0” indicates that between centers effect is negligible)
https://doi.org/10.1371/journal.pone.0204608.t003
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A quarter of the patients in this study received the antibiotic carbapenem initially. Recent
reports from Turkey reveal the high prevalence of extended-spectrum beta-lactamase produc-
tion among community-acquired E. coli infections [19]. This upward trend in resistance fre-
quency among the most common cause of community-acquired sepsis might partially explain
the high number of carbapenem prescriptions upon admission.
In this study, we chose not to include an administrative time censor for mortality (e.g.
28-day mortality). To set an administrative censor would require the use of a “time-to-event”
analysis. In our opinion, such a time-to-event analysis would not contribute appreciably to the
main purpose of this study, which was to develop an improved scoring system.
The major weakness of this study is its retrospective design, which represents a source of
potential selection bias, especially regarding age. Another limitation is the relatively small sam-
ple size in this study, which weakens the generalizability of the findings. We, therefore, suggest
validating the predictive performance of the mod-qSOFA score in prospective studies. One
other limitation is the high number of negative blood culture results. Because of the high pro-
portion of negative blood cultures, we could not adjust our estimates with such a significant
confounder. However, the poor sensitivity of blood cultures in community-acquired sepsis
syndrome is quite ordinary [20]. We believe that adjusting a multivariate model by the ade-
quacy of antibiotic treatment using a minor subset of the cohort (a subset with positive blood
cultures) would generate biased estimates.
Fig 1. The model-based decision tree for fatal outcomes among patients with sepsis syndrome. The fatal outcome is first partitioned among stages of sepsis (SOS).
Sepsis node partitioned by time to antibiotics, followed by age. Age partitioned severe sepsis and septic shock nodes. Terminal nodes displayed as bar plots giving the
percentages of fatal outcomes in the node. Of notice was the patients under 50 years old who received antibiotics within three hours were all survived.
https://doi.org/10.1371/journal.pone.0204608.g001
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Conclusions
We propose the implementation of the mod-qSOFA in EDs toward improving early identifica-
tion of high-risk patients with sepsis syndrome along with other measures. Adopting this mod-
ified assessment system may improve patient stratification, facilitate appropriate allocation of
resources, and optimize patient care.
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